363 related articles for article (PubMed ID: 24462575)
1. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.
Ireland PM; Marshall L; Norville I; Sarkar-Tyson M
Microb Pathog; 2014; 67-68():55-8. PubMed ID: 24462575
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection.
Pinweha P; Pumirat P; Cuccui J; Jitprasutwit N; Muangsombut V; Srinon V; Boonyuen U; Thiennimitr P; Vattanaviboon P; Cia F; Willcocks S; Bancroft GJ; Wren BW; Korbsrisate S
PLoS One; 2018; 13(5):e0196202. PubMed ID: 29771915
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl-Prolyl Isomerase
Bzdyl NM; Scott NE; Norville IH; Scott AE; Atkins T; Pang S; Sarovich DS; Coombs G; Inglis TJJ; Kahler CM; Sarkar-Tyson M
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331957
[No Abstract] [Full Text] [Related]
4. Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.
Challacombe JF; Stubben CJ; Klimko CP; Welkos SL; Kern SJ; Bozue JA; Worsham PL; Cote CK; Wolfe DN
PLoS One; 2014; 9(12):e115951. PubMed ID: 25536074
[TBL] [Abstract][Full Text] [Related]
5. A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.
Wagley S; Vanaporn M; Rinchai D; Conejero L; Lertmemongkolchai G; Bancroft GJ; Titball RW
Microb Pathog; 2017 Jun; 107():175-180. PubMed ID: 28323151
[TBL] [Abstract][Full Text] [Related]
6. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
[TBL] [Abstract][Full Text] [Related]
7. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei.
Hopf V; Göhler A; Eske-Pogodda K; Bast A; Steinmetz I; Breitbach K
Infect Immun; 2014 May; 82(5):2006-15. PubMed ID: 24595140
[TBL] [Abstract][Full Text] [Related]
8. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
Kang WT; Vellasamy KM; Chua EG; Vadivelu J
J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
[TBL] [Abstract][Full Text] [Related]
9. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
10. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
Galyov EE; Brett PJ; DeShazer D
Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
[TBL] [Abstract][Full Text] [Related]
12. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P
J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946
[TBL] [Abstract][Full Text] [Related]
13. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei.
Norville IH; Breitbach K; Eske-Pogodda K; Harmer NJ; Sarkar-Tyson M; Titball RW; Steinmetz I
Microbiology (Reading); 2011 Sep; 157(Pt 9):2629-2638. PubMed ID: 21680634
[TBL] [Abstract][Full Text] [Related]
14. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections.
van Schaik E; Tom M; DeVinney R; Woods DE
Microbes Infect; 2008 Oct; 10(12-13):1291-9. PubMed ID: 18707015
[TBL] [Abstract][Full Text] [Related]
15.
Muangsombut V; Withatanung P; Srinon V; Chantratita N; Stevens MP; Blackwell JM; Korbsrisate S
Front Cell Infect Microbiol; 2017; 7():350. PubMed ID: 28848712
[TBL] [Abstract][Full Text] [Related]
16. The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase.
Eggers CT; Murray IA; Delmar VA; Day AG; Craik CS
Biochem J; 2004 Apr; 379(Pt 1):107-18. PubMed ID: 14705961
[TBL] [Abstract][Full Text] [Related]
17. Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei.
Sun GW; Chen Y; Liu Y; Tan GY; Ong C; Tan P; Gan YH
Mol Microbiol; 2010 May; 76(3):677-89. PubMed ID: 20345664
[TBL] [Abstract][Full Text] [Related]
18. Characterization of New Virulence Factors Involved in the Intracellular Growth and Survival of Burkholderia pseudomallei.
Moule MG; Spink N; Willcocks S; Lim J; Guerra-Assunção JA; Cia F; Champion OL; Senior NJ; Atkins HS; Clark T; Bancroft GJ; Cuccui J; Wren BW
Infect Immun; 2015 Dec; 84(3):701-10. PubMed ID: 26712202
[TBL] [Abstract][Full Text] [Related]
19. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.
Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE
Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823
[TBL] [Abstract][Full Text] [Related]
20. Distinct Pathogenic Patterns of
Chen YL; Hsu DW; Hsueh PT; Chen JA; Shih PJ; Lee S; Lin HH; Chen YS
Am J Trop Med Hyg; 2019 Oct; 101(4):736-745. PubMed ID: 31392941
[No Abstract] [Full Text] [Related]
[Next] [New Search]